Non-pharmacological Prevention of Postoperative Delirium by Occupational Therapy Teams (PREPODOT)

April 26, 2021 updated by: Antonello Penna, University of Chile

Non-pharmacological Prevention of Postoperative Delirium by Occupational Therapy Teams in Patients Older Than 75 Years Undergoing High-risk Elective Surgery

In the world, 230 million surgeries are performed every year and US data indicates that more than a third of patients who undergo surgery are older than 65 years, in which between 10 and 70% develop postoperative delirium (POD). Patients who develop POD have poor outcomes, such as a longer hospital stay, a deterioration in functional and cognitive status, high mortality rates, and an increase in health costs.

Delirium is an entity that in a significant percentage is preventable, thus preventing the development of POD is fundamental. In fact, in older adults hospitalized in the no surgical ward, the implementation of non-pharmacological prevention measures of delirium has consistently shown to significantly prevent the development of this condition. However, limited information is available about the usefulness of non-pharmacological intervention protocols applied in the perioperative context to prevent POD.

The main aim of this project is to determine whether the application of non-pharmacological measures during the perioperative period prevents POD in elderly patients undergoing highly complex elective surgeries.

The hypothesis is that the application of these measures decreases the incidence of delirium in this population.

Study Overview

Detailed Description

To determine whether non-pharmacological measures decrease the incidence of POD during the perioperative period in elderly patients undergoing highly complex elective surgeries, it will be performed a randomized clinical trial, where two groups of patients older than 75 years undergoing highly complex elective surgeries will be compared:

  1. The first group will receive a protocol of non-pharmacological interventions implemented by occupational therapy teams to prevent delirium plus standard non-pharmacological prevention interventions.
  2. The second group will only receive standard non-pharmacological prevention interventions.

This study will be carried out in the surgical units of the Hospital Clinico de la Universidad de Chile (HCUCH) and in the Hospital San Jose (HSJ).

The expected result is to demonstrate that the interventions carried out by occupational therapists decrease the incidence of DPO in a significant way in comparison with standard prevention intervention.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • RM
      • Santiago, RM, Chile, 7690306
        • Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

75 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Hospital admission for highly complex elective surgery

Exclusion Criteria:

  • History of cognitive impairment.
  • A low score in Mini-Mental State Examination (MMSE): <23 points if the patient has 6 or more years of schooling, and <18 points if the patient has <6 years of schooling.
  • Severe communication disorder and cultural language limitation (language other than Spanish).
  • Delirium on admission or prior to the start of the intervention (measured with CAM).
  • Patient enrolled in another study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Standard non-pharmacological intervention during 5 days after surgery.
Prevention of postoperative delirium using standard non-pharmacological prevention measures
Experimental: Treatment
Occupational therapy intervention twice a day plus standard non-pharmacological prevention intervention during 5 days after surgery.
Prevention of postoperative delirium using standard non-pharmacological prevention measures
Prevention of postoperative delirium by occupational therapy intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium
Time Frame: 5 days
Developing postoperative delirium evaluated by CAM (complete criteria for delirium diagnostic)
5 days
Subsyndromal delirium
Time Frame: 5 days
Developing postoperative subsyndromal delirium evaluated by CAM (incomplete criteria for delium diagnostic)
5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lenght of hospital stay
Time Frame: 30 days
Number of days between admission and discharge to the hospital
30 days
Mortality
Time Frame: 30 days
Percentage of patients who die between the day of surgery and 30 days after surgery
30 days
Severity of delirium
Time Frame: 5 days
Severity of delirium will be evaluated with questionnaire CAM-S
5 days
Duration of delirium
Time Frame: 5 days
Number of days in which the patients have delirium
5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antonello Penna, MD/PhD, University of Chile
  • Principal Investigator: Eduardo Tobar, MD, University of Chile
  • Principal Investigator: Veronica Rojas, Nurse/MSc, University of Chile
  • Principal Investigator: Evelyn Alvarez, TO/MSc, Universidad Central/Universidad de Chile
  • Principal Investigator: Constanza Briceño, TO/MSc, University of Chile
  • Principal Investigator: Felipe Salech, MD/PhD, University of Chile
  • Principal Investigator: Daniela Ponce, Ing, University of Chile
  • Principal Investigator: Gonzalo Navarrete, MD, University of Chile

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2018

Primary Completion (Actual)

March 9, 2021

Study Completion (Actual)

March 9, 2021

Study Registration Dates

First Submitted

October 7, 2018

First Submitted That Met QC Criteria

October 9, 2018

First Posted (Actual)

October 12, 2018

Study Record Updates

Last Update Posted (Actual)

April 28, 2021

Last Update Submitted That Met QC Criteria

April 26, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Clinical Trials on Standard non-pharmacological prevention intervention

3
Subscribe